PubMed

A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: The VIA study.

Potter MJ, Claudio CC, Szabo SM.

Br J Ophthalmol. 2009 Jun 10. [Epub ahead of print]PMID: 19520690 [PubMed - as supplied by publisher]Related articles

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles

Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.

Lazic R, Gabric N.

Ophthalmology. 2007 Jun;114(6):1179-85.PMID: 17544776 [PubMed - indexed for MEDLINE]Related articles

One-year follow-up of combined customized therapy. Photodynamic therapy and bevacizumab for exudative age-related macular degeneration.

Navea A, Mataix J, Desco MC, Garcia-Pous M, Palacios E.

Retina. 2009 Jan;29(1):13-9.PMID: 18854782 [PubMed - indexed for MEDLINE]Related articles

Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

Chaudhary V, Mao A, Hooper PL, Sheidow TG.

Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

[Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]

Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, Vécsei-Marlovits P, Schmidt-Erfurth U.

Ophthalmologe. 2007 Jul;104(7):588-93. German. PMID: 17564719 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results.

Sacu S, Michels S, Prager F, Weigert G, Dunavoelgyi R, Geitzenauer W, Pruente C, Schmidt-Erfurth U.

Eye (Lond). 2009 Jan 23. [Epub ahead of print]PMID: 19169239 [PubMed - as supplied by publisher]Related articles

Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.

Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA, Tewari A.

Retina. 2006 Nov-Dec;26(9):988-93.PMID: 17151484 [PubMed - indexed for MEDLINE]Related articles

Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

Melamud A, Stinnett S, Fekrat S.

Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

Bashshur ZF, Schakal A, Hamam RN, El Haibi CP, Jaafar RF, Noureddin BN.

Arch Ophthalmol. 2007 Oct;125(10):1357-61.PMID: 17923543 [PubMed - indexed for MEDLINE]Related articlesFree article

Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.

Bakri SJ, Couch SM, McCannel CA, Edwards AO.

Retina. 2009 May;29(5):573-8.PMID: 19430278 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.

Br J Ophthalmol. 2006 Mar;90(3):337-41.PMID: 16488958 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.

Singh CN, Saperstein DA.

Retina. 2008 Jun;28(6):789-93.PMID: 18536593 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

Spaide RF, Sorenson J, Maranan L.

Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Verteporfin In Photodynamic Therapy Study Group.

Am J Ophthalmol. 2001 May;131(5):541-60.PMID: 11336929 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles